Quest Diagnostics Inc vs Tripadvisor Inc Common Stock — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Tripadvisor Inc Common Stock trades at $11.04 (market cap $1.28B). The key difference: Quest Diagnostics Inc is far larger — about 20.5× Tripadvisor Inc Common Stock's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Tripadvisor Inc Common Stock pays none. Which is the better fit depends on your goals.
| DGX | TRIP | |
|---|---|---|
Market Cap | $26.21B | $1.28B |
Sector | Health | Consumer Cyclical |
52-Week High | $238.50 | $19.14 |
52-Week Low | $173.49 | $9.24 |
Enterprise Value | $31.97B | $1.33B |
Dividend Yield | 1.45% | — |
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →